Home Sectors Healthcare Current Trend: Henry Schein (NASDAQ: HSIC)

Current Trend: Henry Schein (NASDAQ: HSIC)


Henry Schein is in the medical distribution industry and is part of the healthcare sector. The company CEO is Stanley M. Bergman. Henry Schein Inc is a provider of healthcare products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics.

Previous Intraday Trading Performance:

The HSIC stock showed a previous change of -25.78% with an open at 61.82 and a close of 59.15. It reached an intraday high of 62.45 and a low of 57.78.

SeekingAlpha:  Midday movers and shakers


The stock has a market cap of $9.0b with 152.4m shares outstanding, of which the float is 150.6m shares. Trading volume reached 5,744,789 shares compared to its average volume of 1,774,268 shares. Based on the current average volume and close price, the trading liquidity is good.

Historical Trading Performance:

Over the last five trading days, Henry Schein shares returned -24.59% and in the past 30 trading days it returned -23.98%. Over three months, it changed -27.16%. In one year it has changed -25.51% and within that year its 52-week high was 91.35 and its 52-week low was 57.78. HSIC stock is 2.37% above its 52 Week Low.

Our calculations show a 200 day moving average of 78.89 and a 50 day moving average of 79.87. Currently HSIC stock is trading -25.02% below its 200 day moving average and may not be a good opportunity to buy as it may continue to trend down.

PR Newswire:  Henry Schein Completes Spin-Off Of Global Animal Health Business


The last annual fiscal EPS for the company was reported at 2.57 that ended on 31st of December 2017, which according to the previous close, that is a PE of 23.02. Based on 9 analyst estimates, the consensus EPS for the next quarter is 1.11. The TTM EPS is 3.99, which comes to a TTM PE of 14.82. Historically, the PE high was 32.20 and the PE low was 14.82. HSIC stock has set a new PE low record!

The following are the last four quarter reported earnings per share:
09-30-2018:  1.03
06-30-2018:  1.04
03-31-2018:  0.95
12-31-2017:  0.97

Base on our calculations, the intrinsic value per share is 64.08, which means it is possibly undervalued and has a margin of safety of 7.70%

Indicators to Watch:

Based on the latest filings, there is 148.90% of institutional ownership. Short-interest is 0, which is 0.00% of shares outstanding. The short-interest ratio or days-to-cover ratio is 0.00.

The current calculated beta is 0.92

PR Newswire:  Henry Schein Completes Spin-Off Of Global Animal Health Business

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is 13.25%, return on assets is 4.99%, profit margin is 4.31%, price-to-sales is 1.24 and price-to-book is 3.03.

Company Scores:

All scores are out of six:
 0  :Valuation Score
 2  :Past Performance Score
 4  :Financial Strength Score
 1  :Future Growth Score
 0  :Dividend Score
 1  :Overall Score

John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.